Sensus Healthcare, Inc.SRTSNASDAQ
LOADING
|||
R&D Expense Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
23.66%
↑ 168% above average
Average (39q)
8.83%
Historical baseline
Range
High:86.62%
Low:-43.55%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 23.66% |
| Q2 2025 | -43.55% |
| Q1 2025 | 66.94% |
| Q4 2024 | 80.88% |
| Q3 2024 | -0.35% |
| Q2 2024 | -6.48% |
| Q1 2024 | 36.58% |
| Q4 2023 | -37.40% |
| Q3 2023 | 31.75% |
| Q2 2023 | -25.14% |
| Q1 2023 | -5.18% |
| Q4 2022 | 55.23% |
| Q3 2022 | -9.79% |
| Q2 2022 | 13.60% |
| Q1 2022 | -34.12% |
| Q4 2021 | 48.52% |
| Q3 2021 | -19.57% |
| Q2 2021 | 39.94% |
| Q1 2021 | -21.51% |
| Q4 2020 | -10.50% |
| Q3 2020 | -18.03% |
| Q2 2020 | -6.29% |
| Q1 2020 | 28.99% |
| Q4 2019 | -39.42% |
| Q3 2019 | -18.98% |
| Q2 2019 | -1.56% |
| Q1 2019 | 32.39% |
| Q4 2018 | -13.32% |
| Q3 2018 | 9.41% |
| Q2 2018 | 4.53% |
| Q1 2018 | -11.62% |
| Q4 2017 | 12.89% |
| Q3 2017 | 29.49% |
| Q2 2017 | 2.10% |
| Q1 2017 | 56.10% |
| Q4 2016 | 86.62% |
| Q3 2016 | -5.77% |
| Q2 2016 | 40.97% |
| Q1 2016 | -12.24% |
| Q4 2015 | -6.75% |